Pseudotumor cerebri due to hypervitaminosis A or hypervitaminosis D or both in Alagille syndrome.
Ertekin
Vildan
V
Selimoğlu
Mukadder Ayşe
MA
Tan
Hüseyin
H
D016738:Alagille Syndrome / Q000150:complications* / Q000503:physiopathology; D001361:Avitaminosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D001659:Biliary Tract / Q000503:physiopathology; D002675:Child, Preschool; D002779:Cholestasis / Q000150:complications* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006986:Hypervitaminosis A / Q000139:chemically induced / Q000150:complications* / Q000503:physiopathology; D019586:Intracranial Hypertension / Q000139:chemically induced / Q000503:physiopathology; D008297:Male; D011559:Pseudotumor Cerebri / Q000139:chemically induced* / Q000503:physiopathology; D014801:Vitamin A / Q000009:adverse effects; D014802:Vitamin A Deficiency / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014807:Vitamin D / Q000009:adverse effects; D014808:Vitamin D Deficiency / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology
D014801:Vitamin A; D014807:Vitamin D